Nilotinib Effects on Safety, Tolerability, and Potential Biomarkers in Parkinson Disease

JAMA Neurology Author Interviews - A podcast by JAMA Network - Mondays

Interview with Charbel Moussa, MD, PhD, author of Nilotinib Effects on Safety, Tolerability, and Potential Biomarkers in Parkinson Disease: A Phase 2 Randomized Clinical Trial